Rodencal, Jason
Dixon, Scott J. http://orcid.org/0000-0001-6230-8199
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM122923)
Article History
First Online: 13 January 2022
Competing interests
: S.J.D. is a founder of Prothegen Inc., is a member of the scientific advisory boards for Ferro Therapeutics and Hillstream Biopharma, and holds patents related to ferroptosis. J.R. declares no competing interests.